Literature DB >> 21928115

Isolation of a new cell population in the glioblastoma microenvironment.

Anne Clavreul1, Amandine Etcheverry, Agnès Chassevent, Véronique Quillien, Tony Avril, Marie-Lise Jourdan, Sophie Michalak, Patrick François, Jean-Luc Carré, Jean Mosser, Philippe Menei.   

Abstract

Glioblastoma (GB) is a highly infiltrative tumor recurring in 90% of cases within a few centimeters of the resection cavity, even in cases of complete tumor resection and adjuvant chemo/radiotherapy. This observation highlights the importance of understanding this special zone of brain tissue surrounding the tumor. It is becoming clear that the nonneoplastic stromal compartment of most solid cancers plays an active role in tumor proliferation, invasion, and metastasis. Very little information, other than that concerning angiogenesis and immune cells, has been collected for stromal cells from GB. As part of a translational research program, we have isolated a new stromal cell population surrounding GB by computer-guided stereotaxic biopsies and primary culture. We named these cells GB-associated stromal cells (GASCs). GASCs are diploid, do not display the genomic alterations typical of GB cells, and have phenotypic and functional properties in common with the cancer-associated fibroblasts (CAFs) described in the stroma of carcinomas. In particular, GASCs express markers associated with CAFs such as fibroblast surface protein, alpha-smooth muscle actin (α-SMA), and platelet-derived growth factor receptor-beta (PDGFRβ). Furthermore, GASCs have a molecular expression profile different from that of control stromal cells derived from non-GB peripheral brain tissues. GASCs were also found to have tumor-promoting effects on glioma cells in vitro and in vivo. The isolation of GASCs in a tumor of neuroepithelial origin was unexpected, and further studies are required to determine their potential as a target for antiglioma treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21928115     DOI: 10.1007/s11060-011-0701-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  48 in total

1.  A hierarchy of self-renewing tumor-initiating cell types in glioblastoma.

Authors:  Ruihuan Chen; Merry C Nishimura; Stephanie M Bumbaca; Samir Kharbanda; William F Forrest; Ian M Kasman; Joan M Greve; Robert H Soriano; Laurie L Gilmour; Celina Sanchez Rivers; Zora Modrusan; Serban Nacu; Steve Guerrero; Kyle A Edgar; Jeffrey J Wallin; Katrin Lamszus; Manfred Westphal; Susanne Heim; C David James; Scott R VandenBerg; Joseph F Costello; Scott Moorefield; Cynthia J Cowdrey; Michael Prados; Heidi S Phillips
Journal:  Cancer Cell       Date:  2010-04-13       Impact factor: 31.743

Review 2.  Molecular biology of cancer-associated fibroblasts: can these cells be targeted in anti-cancer therapy?

Authors:  Tamas A Gonda; Andrea Varro; Timothy C Wang; Benjamin Tycko
Journal:  Semin Cell Dev Biol       Date:  2009-10-17       Impact factor: 7.727

3.  Determinants for the establishment of permanent tissue culture lines from human gliomas.

Authors:  B Westermark; J Pontén; R Hugosson
Journal:  Acta Pathol Microbiol Scand A       Date:  1973-11

4.  Arrested neural and advanced mesenchymal differentiation of glioblastoma cells-comparative study with neural progenitors.

Authors:  Piotr Rieske; Ewa Golanska; Magdalena Zakrzewska; Sylwester Piaskowski; Krystyna Hulas-Bigoszewska; Magdalena Wolańczyk; Malgorzata Szybka; Monika Witusik-Perkowska; Dariusz J Jaskolski; Krzysztof Zakrzewski; Wojciech Biernat; Barbara Krynska; Pawel P Liberski
Journal:  BMC Cancer       Date:  2009-02-14       Impact factor: 4.430

5.  Malignant astrocytomas: focal tumor recurrence after focal external beam radiation therapy.

Authors:  B C Liang; A F Thornton; H M Sandler; H S Greenberg
Journal:  J Neurosurg       Date:  1991-10       Impact factor: 5.115

6.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

Review 7.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.

Authors:  Kornelia Polyak; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2009-03-05       Impact factor: 60.716

8.  Genomic changes in progression of low-grade gliomas.

Authors:  Ahmed Idbaih; Rosana Carvalho Silva; Emmanuelle Crinière; Yannick Marie; Catherine Carpentier; Blandine Boisselier; Sophie Taillibert; Audrey Rousseau; Karima Mokhtari; François Ducray; Joelle Thillet; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre
Journal:  J Neurooncol       Date:  2008-07-11       Impact factor: 4.130

Review 9.  Cancer associated fibroblasts in cancer pathogenesis.

Authors:  Omar E Franco; Aubie K Shaw; Douglas W Strand; Simon W Hayward
Journal:  Semin Cell Dev Biol       Date:  2009-11-05       Impact factor: 7.727

10.  Mesenchymal differentiation of glioblastoma stem cells.

Authors:  L Ricci-Vitiani; R Pallini; L M Larocca; D G Lombardi; M Signore; F Pierconti; G Petrucci; N Montano; G Maira; R De Maria
Journal:  Cell Death Differ       Date:  2008-05-23       Impact factor: 15.828

View more
  25 in total

1.  Glioma cells escaped from cytotoxicity of temozolomide and vincristine by communicating with human astrocytes.

Authors:  Weiliang Chen; Donghai Wang; Xinwen Du; Ying He; Songyu Chen; Qianqian Shao; Chao Ma; Bin Huang; Anjing Chen; Peng Zhao; Xun Qu; Xingang Li
Journal:  Med Oncol       Date:  2015-01-29       Impact factor: 3.064

2.  Characterizing the peritumoral brain zone in glioblastoma: a multidisciplinary analysis.

Authors:  Jean-Michel Lemée; Anne Clavreul; Marc Aubry; Emmanuelle Com; Marie de Tayrac; Pierre-Antoine Eliat; Cécile Henry; Audrey Rousseau; Jean Mosser; Philippe Menei
Journal:  J Neurooncol       Date:  2015-01-06       Impact factor: 4.130

3.  Effect of cancer-associated fibroblasts on the migration of glioma cells in vitro.

Authors:  Jana Trylcova; Petr Busek; Karel Smetana; Eva Balaziova; Barbora Dvorankova; Alzbeta Mifkova; Aleksi Sedo
Journal:  Tumour Biol       Date:  2015-02-25

4.  Identification of two glioblastoma-associated stromal cell subtypes with different carcinogenic properties in histologically normal surgical margins.

Authors:  Anne Clavreul; Amandine Etcheverry; Clément Tétaud; Audrey Rousseau; Tony Avril; Cécile Henry; Jean Mosser; Philippe Menei
Journal:  J Neurooncol       Date:  2014-12-13       Impact factor: 4.130

Review 5.  Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.

Authors:  Jean-Michel Lemée; Anne Clavreul; Philippe Menei
Journal:  Neuro Oncol       Date:  2015-07-22       Impact factor: 12.300

6.  Lighting a Fire: Gasdermin-Mediated Pyroptosis Remodels the Glioma Microenvironment and Promotes Immune Checkpoint Blockade Response.

Authors:  Yonghua Cai; Ke Li; Jie Lin; Xianqiu Liang; Wei Xu; Zhengming Zhan; Shuaishuai Xue; Yu Zeng; Peng Chai; Yangqi Mao; Zibin Song; Lei Han; Ye Song; Xian Zhang; Hai Wang
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

7.  MicroRNA regulating stanniocalcin-1 is a metastasis and dissemination promoting factor in glioblastoma.

Authors:  Junichi Sakata; Takashi Sasayama; Kazuhiro Tanaka; Hiroaki Nagashima; Mitsutoshi Nakada; Hirotomo Tanaka; Naoya Hashimoto; Naoki Kagawa; Manabu Kinoshita; Satoshi Nakamizo; Masahiro Maeyama; Masamitsu Nishihara; Kohkichi Hosoda; Eiji Kohmura
Journal:  J Neurooncol       Date:  2019-01-30       Impact factor: 4.130

8.  IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.

Authors:  Manuel Röhrich; Anastasia Loktev; Annika K Wefers; Annette Altmann; Daniel Paech; Sebastian Adeberg; Paul Windisch; Thomas Hielscher; Paul Flechsig; Ralf Floca; Dominik Leitz; Julius P Schuster; Peter E Huber; Jürgen Debus; Andreas von Deimling; Thomas Lindner; Uwe Haberkorn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-06       Impact factor: 9.236

9.  Intraoperative vascular DIVA surgery reveals angiogenic hotspots in tumor zones of malignant gliomas.

Authors:  Ilker Y Eyüpoglu; Nirjhar Hore; Zheng Fan; Rolf Buslei; Andreas Merkel; Michael Buchfelder; Nicolai E Savaskan
Journal:  Sci Rep       Date:  2015-01-22       Impact factor: 4.379

Review 10.  Oncogenesis, Microenvironment Modulation and Clinical Potentiality of FAP in Glioblastoma: Lessons Learned from Other Solid Tumors.

Authors:  Yixin Shi; Ziren Kong; Penghao Liu; Guozhu Hou; Jiaming Wu; Wenbin Ma; Xin Cheng; Yu Wang
Journal:  Cells       Date:  2021-05-10       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.